KalVista Pharmaceuticals (KALV) Shares Outstanding (2014 - 2025)

KalVista Pharmaceuticals' Shares Outstanding history runs 12 years deep, the most recent figure standing at $50.3 million for Q3 2025.

• In Q3 2025, Shares Outstanding rose 16.85% year-over-year to $50.3 million; the TTM figure through Jul 2025 stood at $50.3 million (up 16.85% YoY), while the FY2025 annual figure was $49.8 million, up 17.03% from the prior year.
• Shares Outstanding came in at $50.3 million for Q3 2025 at KalVista Pharmaceuticals, up from $49.8 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $50.3 million in Q3 2025 to a low of $18.0 million in Q1 2021.
• A 5-year average of $33.7 million and a median of $34.2 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding increased 0.52% in 2022 and soared 39.91% in 2023, its largest moves.
• KalVista Pharmaceuticals' Shares Outstanding stood at $24.4 million in 2021, then climbed by 0.65% to $24.6 million in 2022, then surged by 39.91% to $34.4 million in 2023, then surged by 43.61% to $49.4 million in 2024, then increased by 1.83% to $50.3 million in 2025.
• According to Business Quant data, Shares Outstanding over the past three periods registered $50.3 million, $49.8 million, and $49.4 million for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison